These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 19912310)

  • 1. Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease.
    Mirre E; Brousse V; Berteloot L; Lambot-Juhan K; Verlhac S; Boulat C; Dumont MD; Lenoir G; de Montalembert M
    Eur J Haematol; 2010 Mar; 84(3):259-65. PubMed ID: 19912310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
    Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
    J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia.
    Bishop S; Matheus MG; Abboud MR; Cane ID; Adams RJ; Jackson SM; Kalpatthi R
    Blood Cells Mol Dis; 2011 Aug; 47(2):125-8. PubMed ID: 21724428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The other side of abnormal: a case series of low transcranial Doppler velocities associated with stroke in children with sickle cell disease.
    Buchanan ID; James-Herry A; Osunkwo I
    J Pediatr Hematol Oncol; 2013 Oct; 35(7):543-6. PubMed ID: 23211694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of transcranial Doppler ultrasonography screening and primary stroke prevention in urban and rural sickle cell disease populations.
    Hussain S; Nichols F; Bowman L; Xu H; Neunert C
    Pediatr Blood Cancer; 2015 Feb; 62(2):219-223. PubMed ID: 25381872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Big strokes in small persons.
    Adams RJ
    Arch Neurol; 2007 Nov; 64(11):1567-74. PubMed ID: 17998439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
    Wang WC; Dwan K
    Cochrane Database Syst Rev; 2013 Nov; (11):CD003146. PubMed ID: 24226646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcranial Doppler velocity and brain MRI/MRA changes in children with sickle cell anemia on chronic transfusions to prevent primary stroke.
    Sheehan VA; Hansbury EN; Smeltzer MP; Fortner G; McCarville MB; Aygun B
    Pediatr Blood Cancer; 2013 Sep; 60(9):1499-502. PubMed ID: 23625812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation.
    Cherry MG; Greenhalgh J; Osipenko L; Venkatachalam M; Boland A; Dundar Y; Marsh K; Dickson R; Rees DC
    Health Technol Assess; 2012; 16(43):1-129. PubMed ID: 23140544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia.
    Miller ST; Wright E; Abboud M; Berman B; Files B; Scher CD; Styles L; Adams RJ;
    J Pediatr; 2001 Dec; 139(6):785-9. PubMed ID: 11743502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease.
    Adams RJ; Brambilla D;
    N Engl J Med; 2005 Dec; 353(26):2769-78. PubMed ID: 16382063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing stroke among children with sickle cell anemia: an analysis of strategies that involve transcranial Doppler testing and chronic transfusion.
    Mazumdar M; Heeney MM; Sox CM; Lieu TA
    Pediatrics; 2007 Oct; 120(4):e1107-16. PubMed ID: 17768181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.
    Adams RJ; McKie VC; Hsu L; Files B; Vichinsky E; Pegelow C; Abboud M; Gallagher D; Kutlar A; Nichols FT; Bonds DR; Brambilla D
    N Engl J Med; 1998 Jul; 339(1):5-11. PubMed ID: 9647873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of pediatric sickle cell disease patients with abnormal high velocities on transcranial Doppler.
    Bernaudin F; Verlhac S; Coïc L; Lesprit E; Brugières P; Reinert P
    Pediatr Radiol; 2005 Mar; 35(3):242-8. PubMed ID: 15703901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of the DREPAGREFFE trial: A prospective controlled multicenter study evaluating the benefit of genoidentical hematopoietic stem cell transplantation over chronic transfusion in sickle cell anemia children detected to be at risk of stroke by transcranial Doppler (NCT 01340404).
    Chevret S; Verlhac S; Ducros-Miralles E; Dalle JH; de Latour RP; de Montalembert M; Benkerrou M; Pondarré C; Thuret I; Guitton C; Lesprit E; Etienne-Julan M; Elana G; Vannier JP; Lutz P; Neven B; Galambrun C; Paillard C; Runel C; Jubert C; Arnaud C; Kamdem A; Brousse V; Missud F; Petras M; Doumdo-Divialle L; Berger C; Fréard F; Taieb O; Drain E; Elmaleh M; Vasile M; Khelif Y; Bernaudin M; Chadebech P; Pirenne F; Socié G; Bernaudin F
    Contemp Clin Trials; 2017 Nov; 62():91-104. PubMed ID: 28821470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke prevention.
    Kwiatkowski JL; Cohen AR; Garro J; Alvarez O; Nagasubramanian R; Sarnaik S; Thompson A; Woods GM; Schultz W; Mortier N; Lane P; Mueller B; Yovetich N; Ware RE;
    Am J Hematol; 2012 Feb; 87(2):221-3. PubMed ID: 22120913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.
    Ware RE; Davis BR; Schultz WH; Brown RC; Aygun B; Sarnaik S; Odame I; Fuh B; George A; Owen W; Luchtman-Jones L; Rogers ZR; Hilliard L; Gauger C; Piccone C; Lee MT; Kwiatkowski JL; Jackson S; Miller ST; Roberts C; Heeney MM; Kalfa TA; Nelson S; Imran H; Nottage K; Alvarez O; Rhodes M; Thompson AA; Rothman JA; Helton KJ; Roberts D; Coleman J; Bonner MJ; Kutlar A; Patel N; Wood J; Piller L; Wei P; Luden J; Mortier NA; Stuber SE; Luban NLC; Cohen AR; Pressel S; Adams RJ
    Lancet; 2016 Feb; 387(10019):661-670. PubMed ID: 26670617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke prevention trial in sickle cell anemia.
    Adams RJ; McKie VC; Brambilla D; Carl E; Gallagher D; Nichols FT; Roach S; Abboud M; Berman B; Driscoll C; Files B; Hsu L; Hurlet A; Miller S; Olivieri N; Pegelow C; Scher C; Vichinsky E; Wang W; Woods G; Kutlar A; Wright E; Hagner S; Tighe F; Waclawiw MA
    Control Clin Trials; 1998 Feb; 19(1):110-29. PubMed ID: 9492971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic transfusion practices for prevention of primary stroke in children with sickle cell anemia and abnormal TCD velocities.
    Aygun B; Wruck LM; Schultz WH; Mueller BU; Brown C; Luchtman-Jones L; Jackson S; Iyer R; Rogers ZR; Sarnaik S; Thompson AA; Gauger C; Helms RW; Ware RE;
    Am J Hematol; 2012 Apr; 87(4):428-30. PubMed ID: 22231377
    [No Abstract]   [Full Text] [Related]  

  • 20. A pilot study of manual chronic partial exchange transfusion in children with sickle disease.
    Aloni MN; Lê PQ; Heijmans C; Huybrechts S; Devalck C; Azzi N; Ngalula-Mujinga M; Ferster A
    Hematology; 2015 Jun; 20(5):284-8. PubMed ID: 25133935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.